Transgene Biotek Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 1.411 million compared to INR 438,470 a year ago. Net loss was INR 26.078 million compared to INR 27.869 million a year ago. Basic loss per share from continuing operations was INR 0.34 compared to INR 0.37 a year ago. For the full year, total revenue was INR 4.364 million compared to INR 1.824 million a year ago. Net loss was INR 104.346 million compared to INR 109.622 million a year ago. Basic loss per share from continuing operations was INR 1.38 compared to INR 1.45 a year ago.